Natural Product: NPC5989
Natural Product ID:   | NPC5989 |
Common Name*:   | Phorbol Myristate Acetate |
IUPAC Name:   | n.a. |
Synonyms:   | Phorbol Myristate Acetate |
Standard InCHIKey:   | PHEDXBVPIONUQT-RGYGYFBISA-N |
Standard InCHI:   | InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3/t24-,27+,28-,30-,32-,34-,35-,36-/m1/s1 |
SMILES:   | CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@H]([C@H]3[C@]1(OC(=O)C)C3(C)C)C=C(C[C@]1([C@H]2C=C(C1=O)C)O)CO
|
Synthetic Gene Cluster:   |
n.a. |
ChEMBL Identifier:   |
CHEMBL279115 |
PubChem CID:   |
27924 |
Chemical Classification**:   |
-
CHEMONTID:0000000 [Organic compounds]
-
[CHEMONTID:0000012] Lipids and lipid-like molecules
-
[CHEMONTID:0000259] Prenol lipids
[CHEMONTID:0001551] Diterpenoids[CHEMONTID:0002875] Tigliane and ingenane diterpenoids[CHEMONTID:0002906] Phorbol esters
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
  Species Source
Organism ID |
Organism Name |
Taxonomy Level |
Family |
SuperKingdom |
Isolation Part |
Collection Location |
Collection Time |
Reference |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[10075762] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[10654416] |
NPO9973 |
Euphorbia turczaninowii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[11520228] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
seed |
n.a. |
PMID[14577694] |
NPO26327 |
Chaenomeles sinensis |
Species |
Rosaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[14600382] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
n.a. |
whole plant |
n.a. |
PMID[16394559] |
NPO40906 |
Peruvian amazonian |
Species |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
PMID[18163590] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[20014777] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
seed |
n.a. |
PMID[21049973] |
NPO13882 |
Euphorbia grandicornis |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
aerial part |
n.a. |
PMID[21319774] |
NPO19424 |
Trigonostemon howii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
twig |
n.a. |
PMID[21520897] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
seeds |
n.a. |
n.a. |
PMID[21942765] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
seed |
n.a. |
PMID[21942765] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[22459211] |
NPO19424 |
Trigonostemon howii |
Species |
Euphorbiaceae |
Eukaryota |
Stems |
n.a. |
n.a. |
PMID[23148674] |
NPO19424 |
Trigonostemon howii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[23215460] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[23701597] |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[24433009] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[24456525] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
Seeds |
n.a. |
n.a. |
PMID[24597776] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[25819096] |
NPO26327 |
Chaenomeles sinensis |
Species |
Rosaceae |
Eukaryota |
Twigs |
n.a. |
n.a. |
PMID[25894905] |
NPO13882 |
Euphorbia grandicornis |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[27731641] |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[28032759] |
NPO26327 |
Chaenomeles sinensis |
Species |
Rosaceae |
Eukaryota |
Twigs |
n.a. |
n.a. |
PMID[28358502] |
NPO1692 |
Aquilaria malaccensis |
Species |
Thymelaeaceae |
Eukaryota |
Seeds |
n.a. |
n.a. |
PMID[28445049] |
NPO20912 |
Wisteria brachybotrys |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[2853205] |
NPO21274 |
Euphorbia semiperfoliata |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[28925702] |
NPO1692 |
Aquilaria malaccensis |
Species |
Thymelaeaceae |
Eukaryota |
Agarwood |
n.a. |
n.a. |
PMID[29083898] |
NPO1692 |
Aquilaria malaccensis |
Species |
Thymelaeaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[30672698] |
NPO1692 |
Aquilaria malaccensis |
Species |
Thymelaeaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
PMID[7320738] |
NPO4152 |
Oleum linderae |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO26327 |
Chaenomeles sinensis |
Species |
Rosaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO8770 |
Euphorbia wallichii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO29390 |
Semen juglandis |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO7170 |
Tylophora ovata |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[HerDing] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO16841 |
Elsholtzia bodinieri |
Species |
Lamiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO29390 |
Semen juglandis |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO26327 |
Chaenomeles sinensis |
Species |
Rosaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO8770 |
Euphorbia wallichii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO4152 |
Oleum linderae |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO7170 |
Tylophora ovata |
Species |
Apocynaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCMID] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TCM_Taiwan] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO26327 |
Chaenomeles sinensis |
Species |
Rosaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[TM-MC] |
NPO2978 |
Croton tiglium |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO14417 |
Iris tectorum |
Species |
Iridaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO26327 |
Chaenomeles sinensis |
Species |
Rosaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO9973 |
Euphorbia turczaninowii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO10494 |
Alpinia katsumadai |
Species |
Staphylinidae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO21274 |
Euphorbia semiperfoliata |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO8770 |
Euphorbia wallichii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO19424 |
Trigonostemon howii |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO20912 |
Wisteria brachybotrys |
Species |
Fabaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO16841 |
Elsholtzia bodinieri |
Species |
Lamiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO5645 |
Silybum marianum |
Species |
Asteraceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO13882 |
Euphorbia grandicornis |
Species |
Euphorbiaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
NPO1692 |
Aquilaria malaccensis |
Species |
Thymelaeaceae |
Eukaryota |
n.a. |
n.a. |
n.a. |
Database[UNPD] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration
Organism ID |
NP ID |
Organism Material Preparation |
Organism Part |
NP Quantity (Standard) |
NP Quantity (Minimum) |
NP Quantity (Maximum) |
Quantity Unit |
Reference |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  Biological Activity
Activity Type |
# Activity |
EC50 |
17 |
ED50 |
1 |
GI50 |
2 |
IC50 |
13 |
Ki |
7 |
Others |
58 |
Potency |
9 |
Activity Type |
# Activity |
Cell Line |
20 |
Individual Protein |
27 |
NON-MOLECULAR |
5 |
Organism |
29 |
Others |
21 |
Protein Family |
2 |
Protein-Protein Interaction |
1 |
SINGLE PROTEIN |
2 |
Target ID |
Target Type |
Target Name |
Target Organism |
Activity Type |
Activity Relation |
Value |
Unit |
Reference |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Ki |
= |
2.5 |
nM |
PMID[504346] |
NPT116 |
Cell Line |
HL-60 |
Homo sapiens |
Activity |
= |
1.32 |
nM min-1 ml-1 |
PMID[504348] |
NPT466 |
Cell Line |
U-937 |
Homo sapiens |
EC50 |
= |
0.45 |
nM |
PMID[504349] |
NPT886 |
Cell Line |
NIH3T3 |
Mus musculus |
GI50 |
= |
0.01 |
ug.mL-1 |
PMID[504352] |
NPT111 |
Cell Line |
K562 |
Homo sapiens |
GI50 |
= |
0.00012 |
ug.mL-1 |
PMID[504352] |
NPT116 |
Cell Line |
HL-60 |
Homo sapiens |
Activity |
= |
3.0 |
nM |
PMID[504358] |
NPT116 |
Cell Line |
HL-60 |
Homo sapiens |
ED100 |
= |
6.0 |
nM |
PMID[504358] |
NPT80 |
Cell Line |
Raji |
Homo sapiens |
Activity |
= |
50.0 |
% |
PMID[504364] |
NPT80 |
Cell Line |
Raji |
Homo sapiens |
Activity |
= |
60.0 |
% |
PMID[504364] |
NPT50 |
Individual Protein |
Tyrosyl-DNA phosphodiesterase 1 |
Homo sapiens |
Potency |
= |
63095.7 |
nM |
PMID[504366] |
NPT51 |
Individual Protein |
Microtubule-associated protein tau |
Homo sapiens |
Potency |
= |
19952.6 |
nM |
PMID[504366] |
NPT531 |
Individual Protein |
Nuclear receptor ROR-gamma |
Mus musculus |
Potency |
= |
10000.0 |
nM |
PMID[504366] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Ki |
= |
6.4 |
nM |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Activity |
= |
108.43 |
% |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Activity |
= |
100.0 |
% |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Activity |
= |
85.31 |
% |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Activity |
= |
80.64 |
% |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Activity |
= |
62.39 |
% |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Activity |
= |
11.14 |
% |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
Activity |
= |
0.58 |
% |
PMID[504367] |
NPT182 |
Individual Protein |
Protein kinase C alpha |
Homo sapiens |
EC50 |
= |
1700000.0 |
nM |
PMID[504369] |
NPT199 |
Individual Protein |
DNA polymerase kappa |
Homo sapiens |
Potency |
n.a. |
39810.7 |
nM |
PMID[504366] |
NPT66 |
Individual Protein |
Acetylcholinesterase |
Electrophorus electricus |
Inhibition |
= |
19.61 |
% |
PMID[504373] |
NPT189 |
Cell Line |
Vero |
Chlorocebus aethiops |
CC50 |
= |
5700.0 |
nM |
PMID[504374] |
NPT890 |
Cell Line |
SNU-387 |
Homo sapiens |
IC50 |
> |
10000.0 |
nM |
PMID[504376] |
NPT80 |
Cell Line |
Raji |
Homo sapiens |
Activity |
= |
60.0 |
% |
PMID[504377] |
NPT80 |
Cell Line |
Raji |
Homo sapiens |
Activity |
= |
50.0 |
% |
PMID[504377] |
NPT49 |
Individual Protein |
DNA-(apurinic or apyrimidinic site) lyase |
Homo sapiens |
Potency |
n.a. |
891.3 |
nM |
PMID[504366] |
NPT891 |
Cell Line |
iNKT |
|
Activity |
= |
8.5 |
% |
PMID[504380] |
NPT466 |
Cell Line |
U-937 |
Homo sapiens |
GI |
= |
50.0 |
% |
PMID[504382] |
NPT111 |
Cell Line |
K562 |
Homo sapiens |
Activity |
= |
38.1 |
% |
PMID[504385] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
Activity |
= |
120.0 |
% |
PMID[504387] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
44.2 |
% |
PMID[504389] |
NPT2740 |
Cell Line |
Neutrophils |
|
Activity |
= |
102.7 |
% |
PMID[504389] |
NPT189 |
Cell Line |
Vero |
Chlorocebus aethiops |
CC50 |
= |
5700.0 |
nM |
PMID[504390] |
NPT83 |
Cell Line |
MCF7 |
Homo sapiens |
Activity |
= |
120.0 |
% |
PMID[504392] |
NPT484 |
Individual Protein |
Luciferin 4-monooxygenase |
Photinus pyralis |
EC50 |
= |
10.0 |
nM |
PMID[504393] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
10.0 |
nM |
PMID[504344] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Epidermal thickness |
= |
62.2 |
n.a. |
PMID[504345] |
NPT760 |
Individual Protein |
Protein kinase C beta |
Homo sapiens |
Ki |
= |
1.8 |
nM |
PMID[504346] |
NPT880 |
Individual Protein |
Protein kinase C gamma |
Homo sapiens |
Ki |
= |
4.9 |
nM |
PMID[504346] |
NPT881 |
Individual Protein |
Protein kinase C delta |
Homo sapiens |
Ki |
= |
0.8 |
nM |
PMID[504346] |
NPT761 |
Individual Protein |
Protein kinase C epsilon |
Homo sapiens |
Ki |
= |
0.45 |
nM |
PMID[504346] |
NPT316 |
Protein Family |
Protein kinase C (PKC) |
Homo sapiens |
Activity |
= |
899.0 |
pM min-1 (mg of protein)-1 |
PMID[504347] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
0.85 |
nM |
PMID[504349] |
NPT2 |
Others |
Unspecified |
|
Activity |
= |
97.3 |
% |
PMID[504351] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Activity |
= |
0.016 |
nmol |
PMID[504353] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Activity |
= |
0.05 |
ug |
PMID[504353] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Activity |
= |
63.0 |
/nmol |
PMID[504353] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
ID50 |
= |
0.0085 |
ug |
PMID[504355] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
ID50 |
= |
0.012 |
ug |
PMID[504355] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
ID50 |
= |
0.04 |
ug |
PMID[504357] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
ID50 |
= |
0.05 |
ug |
PMID[504357] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
15.0 |
nM |
PMID[504358] |
NPT2 |
Others |
Unspecified |
|
ED50 |
= |
15.0 |
nM |
PMID[504358] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Activity |
= |
93.3 |
% |
PMID[504358] |
NPT881 |
Individual Protein |
Protein kinase C delta |
Homo sapiens |
EC50 |
= |
5170.0 |
nM |
PMID[504359] |
NPT761 |
Individual Protein |
Protein kinase C epsilon |
Homo sapiens |
EC50 |
= |
5560.0 |
nM |
PMID[504359] |
NPT887 |
Individual Protein |
Protein kinase C theta |
Homo sapiens |
EC50 |
= |
3190.0 |
nM |
PMID[504359] |
NPT610 |
Others |
Molecular identity unknown |
|
Inhibition |
= |
21.3 |
% |
PMID[504361] |
NPT610 |
Others |
Molecular identity unknown |
|
Inhibition |
= |
18.3 |
% |
PMID[504361] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
10000.0 |
nM |
PMID[504363] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
6309.57 |
nM |
PMID[504363] |
NPT6 |
Organism |
Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
= |
12589.25 |
nM |
PMID[504363] |
NPT2 |
Others |
Unspecified |
|
Activity |
= |
30.2 |
% |
PMID[504364] |
NPT2 |
Others |
Unspecified |
|
Activity |
= |
28.8 |
% |
PMID[504364] |
NPT87 |
Organism |
Aspergillus fumigatus |
Aspergillus fumigatus |
Survival |
= |
26.0 |
% |
PMID[504365] |
NPT2 |
Others |
Unspecified |
|
Potency |
= |
35481.3 |
nM |
PMID[504366] |
NPT533 |
Protein-Protein Interaction |
Runt-related transcription factor 1/Core-binding factor subunit beta |
Homo sapiens |
Potency |
n.a. |
3162.3 |
nM |
PMID[504366] |
NPT888 |
Individual Protein |
78 kDa glucose-regulated protein |
Homo sapiens |
Potency |
n.a. |
10000.0 |
nM |
PMID[504366] |
NPT32 |
Organism |
Mus musculus |
Mus musculus |
Activity |
= |
100.0 |
% |
PMID[504372] |
NPT67 |
Individual Protein |
Cholinesterase |
Equus caballus |
Inhibition |
= |
-6.35 |
% |
PMID[504373] |
NPT856 |
Organism |
Semliki forest virus |
Semliki forest virus |
EC50 |
> |
162000.0 |
nM |
PMID[504374] |
NPT338 |
Organism |
Sindbis virus |
Sindbis virus |
EC50 |
= |
2200.0 |
nM |
PMID[504374] |
NPT2 |
Others |
Unspecified |
|
Ratio CC50/EC50 |
= |
1965.0 |
n.a. |
PMID[504374] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
2.9 |
nM |
PMID[504374] |
NPT164 |
Organism |
Human herpesvirus 4 |
Human herpesvirus 4 |
Activity |
= |
31.5 |
% |
PMID[504377] |
NPT164 |
Organism |
Human herpesvirus 4 |
Human herpesvirus 4 |
Activity |
= |
29.4 |
% |
PMID[504377] |
NPT2 |
Others |
Unspecified |
|
Ki |
= |
0.59 |
nM |
PMID[504378] |
NPT2 |
Others |
Unspecified |
|
IC50 |
= |
0.79 |
nM |
PMID[504378] |
NPT2 |
Others |
Unspecified |
|
Inhibition |
= |
-1.0 |
% |
PMID[504378] |
NPT2 |
Others |
Unspecified |
|
Potency |
n.a. |
35481.3 |
nM |
PMID[504366] |
NPT2 |
Others |
Unspecified |
|
Ratio CC50/EC50 |
= |
1965.0 |
n.a. |
PMID[504383] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
EC50 |
= |
2.9 |
nM |
PMID[504383] |
NPT2 |
Others |
Unspecified |
|
Ratio CC50/EC50 |
= |
220.0 |
n.a. |
PMID[504383] |
NPT24 |
Organism |
Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
= |
0.9 |
nM |
PMID[504383] |
NPT332 |
Organism |
Human immunodeficiency virus type 2 (ISOLATE ROD) |
Human immunodeficiency virus type 2 (ISOLATE ROD) |
EC50 |
= |
0.7 |
nM |
PMID[504383] |
NPT2 |
Others |
Unspecified |
|
Ratio CC50/EC50 |
= |
107377.0 |
n.a. |
PMID[504383] |
NPT610 |
Others |
Molecular identity unknown |
|
Activity |
= |
39.2 |
% |
PMID[504385] |
NPT610 |
Others |
Molecular identity unknown |
|
Activity |
= |
25.0 |
% |
PMID[504385] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Activity |
= |
120.0 |
% |
PMID[504386] |
NPT20529 |
NON-MOLECULAR |
NON-PROTEIN TARGET |
n.a. |
Activity |
= |
420.0 |
% |
PMID[504386] |
NPT316 |
Protein Family |
Protein kinase C (PKC) |
Homo sapiens |
EC50 |
= |
9.5 |
nM |
PMID[504388] |
NPT20632 |
ORGANISM |
Chikungunya virus |
Chikungunya virus |
EC50 |
= |
2.9 |
nM |
PMID[504390] |
NPT2 |
Others |
Unspecified |
|
Ratio CC50/EC50 |
= |
1965.0 |
n.a. |
PMID[504390] |
NPT25273 |
SINGLE PROTEIN |
RAS guanyl releasing protein 3 |
Homo sapiens |
EC50 |
= |
82.0 |
nM |
PMID[504391] |
NPT881 |
Individual Protein |
Protein kinase C delta |
Homo sapiens |
EC50 |
= |
290.0 |
nM |
PMID[504391] |
NPT2 |
Others |
Unspecified |
|
Ratio EC50 |
= |
3.5 |
n.a. |
PMID[504391] |
NPT20556 |
SINGLE PROTEIN |
Replicase polyprotein 1ab |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
12.07 |
% |
PMID[504394] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
Inhibition |
= |
12.61 |
% |
PMID[504395] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
> |
20000.0 |
nM |
PMID[504397] |
NPT20555 |
ORGANISM |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
IC50 |
> |
19952.62 |
nM |
PMID[504397] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
  Chemically structural similarity: I. Similar Active Natural Products in NPASS
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC5989 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 248 |
0.1-0.2 | 1483 |
0.2-0.3 | 4493 |
0.3-0.4 | 7418 |
0.4-0.5 | 13814 |
0.5-0.6 | 7902 |
0.6-0.7 | 5885 |
0.7-0.8 | 1300 |
0.8-0.85 | 30 |
0.85-0.9 | 30 |
0.9-0.95 | 54 |
0.95-1 | 40 |
  Chemically structural similarity: II. Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC5989 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 220 |
0.1-0.2 | 1952 |
0.2-0.3 | 3682 |
0.3-0.4 | 2112 |
0.4-0.5 | 771 |
0.5-0.6 | 242 |
0.6-0.7 | 158 |
0.7-0.8 | 13 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7949 |
Intermediate Similarity |
NPD6371 |
Approved |
0.7815 |
Intermediate Similarity |
NPD8297 |
Approved |
0.7583 |
Intermediate Similarity |
NPD6649 |
Approved |
0.7583 |
Intermediate Similarity |
NPD6650 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6373 |
Approved |
0.7563 |
Intermediate Similarity |
NPD6372 |
Approved |
0.752 |
Intermediate Similarity |
NPD6319 |
Approved |
0.75 |
Intermediate Similarity |
NPD5955 |
Clinical (unspecified phase) |
0.748 |
Intermediate Similarity |
NPD7604 |
Phase 2 |
0.7479 |
Intermediate Similarity |
NPD6881 |
Approved |
0.7479 |
Intermediate Similarity |
NPD6899 |
Approved |
0.7459 |
Intermediate Similarity |
NPD4632 |
Approved |
0.7458 |
Intermediate Similarity |
NPD6675 |
Approved |
0.7458 |
Intermediate Similarity |
NPD6402 |
Approved |
0.7458 |
Intermediate Similarity |
NPD5739 |
Approved |
0.7458 |
Intermediate Similarity |
NPD7128 |
Approved |
0.7438 |
Intermediate Similarity |
NPD8130 |
Phase 1 |
0.7419 |
Intermediate Similarity |
NPD7115 |
Discovery |
0.7417 |
Intermediate Similarity |
NPD4061 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD5344 |
Discontinued |
0.7395 |
Intermediate Similarity |
NPD7899 |
Clinical (unspecified phase) |
0.7395 |
Intermediate Similarity |
NPD5697 |
Approved |
0.7377 |
Intermediate Similarity |
NPD6882 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7102 |
Approved |
0.7355 |
Intermediate Similarity |
NPD7290 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6883 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5345 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7320 |
Approved |
0.7295 |
Intermediate Similarity |
NPD6847 |
Approved |
0.7295 |
Intermediate Similarity |
NPD6617 |
Approved |
0.7295 |
Intermediate Similarity |
NPD6869 |
Approved |
0.7287 |
Intermediate Similarity |
NPD7492 |
Approved |
0.728 |
Intermediate Similarity |
NPD6009 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6012 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6014 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6013 |
Approved |
0.7252 |
Intermediate Similarity |
NPD7736 |
Approved |
0.725 |
Intermediate Similarity |
NPD5954 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD5701 |
Approved |
0.7244 |
Intermediate Similarity |
NPD6054 |
Approved |
0.7231 |
Intermediate Similarity |
NPD6616 |
Approved |
0.7203 |
Intermediate Similarity |
NPD5211 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD6011 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5983 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7640 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7639 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6648 |
Approved |
0.7176 |
Intermediate Similarity |
NPD8293 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD7078 |
Approved |
0.7167 |
Intermediate Similarity |
NPD6008 |
Approved |
0.7132 |
Intermediate Similarity |
NPD6370 |
Approved |
0.7109 |
Intermediate Similarity |
NPD6059 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7507 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6336 |
Discontinued |
0.7094 |
Intermediate Similarity |
NPD4225 |
Approved |
0.7094 |
Intermediate Similarity |
NPD7638 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5141 |
Approved |
0.7077 |
Intermediate Similarity |
NPD8328 |
Phase 3 |
0.7068 |
Intermediate Similarity |
NPD7319 |
Approved |
0.7054 |
Intermediate Similarity |
NPD6015 |
Approved |
0.7054 |
Intermediate Similarity |
NPD6016 |
Approved |
0.7049 |
Intermediate Similarity |
NPD6686 |
Approved |
0.7034 |
Intermediate Similarity |
NPD4696 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5285 |
Approved |
0.7034 |
Intermediate Similarity |
NPD5286 |
Approved |
0.7031 |
Intermediate Similarity |
NPD7516 |
Approved |
0.7016 |
Intermediate Similarity |
NPD6401 |
Clinical (unspecified phase) |
0.7009 |
Intermediate Similarity |
NPD4755 |
Approved |
0.7009 |
Intermediate Similarity |
NPD6083 |
Phase 2 |
0.7009 |
Intermediate Similarity |
NPD6084 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD5988 |
Approved |
0.6953 |
Remote Similarity |
NPD7328 |
Approved |
0.6953 |
Remote Similarity |
NPD7327 |
Approved |
0.6935 |
Remote Similarity |
NPD4634 |
Approved |
0.693 |
Remote Similarity |
NPD6698 |
Approved |
0.693 |
Remote Similarity |
NPD46 |
Approved |
0.6929 |
Remote Similarity |
NPD6274 |
Approved |
0.6917 |
Remote Similarity |
NPD5224 |
Approved |
0.6917 |
Remote Similarity |
NPD5225 |
Approved |
0.6917 |
Remote Similarity |
NPD5226 |
Approved |
0.6917 |
Remote Similarity |
NPD4633 |
Approved |
0.6899 |
Remote Similarity |
NPD7101 |
Approved |
0.6899 |
Remote Similarity |
NPD7100 |
Approved |
0.6891 |
Remote Similarity |
NPD4700 |
Approved |
0.6864 |
Remote Similarity |
NPD7902 |
Approved |
0.686 |
Remote Similarity |
NPD5175 |
Approved |
0.686 |
Remote Similarity |
NPD5174 |
Approved |
0.6855 |
Remote Similarity |
NPD8132 |
Clinical (unspecified phase) |
0.6838 |
Remote Similarity |
NPD5695 |
Phase 3 |
0.6833 |
Remote Similarity |
NPD5223 |
Approved |
0.6825 |
Remote Similarity |
NPD6053 |
Discontinued |
0.6822 |
Remote Similarity |
NPD6335 |
Approved |
0.681 |
Remote Similarity |
NPD6399 |
Phase 3 |
0.6807 |
Remote Similarity |
NPD5696 |
Approved |
0.6794 |
Remote Similarity |
NPD6921 |
Approved |
0.6794 |
Remote Similarity |
NPD8296 |
Approved |
0.6794 |
Remote Similarity |
NPD8380 |
Approved |
0.6794 |
Remote Similarity |
NPD8379 |
Approved |
0.6794 |
Remote Similarity |
NPD8033 |
Approved |
0.6794 |
Remote Similarity |
NPD8378 |
Approved |
0.6794 |
Remote Similarity |
NPD8335 |
Approved |
0.6786 |
Remote Similarity |
NPD1696 |
Phase 3 |
0.6774 |
Remote Similarity |
NPD4730 |
Approved |
0.6774 |
Remote Similarity |
NPD4729 |
Approved |
0.6752 |
Remote Similarity |
NPD5282 |
Discontinued |
0.6752 |
Remote Similarity |
NPD7748 |
Approved |
0.6748 |
Remote Similarity |
NPD4768 |
Approved |
0.6748 |
Remote Similarity |
NPD4767 |
Approved |
0.6744 |
Remote Similarity |
NPD6317 |
Approved |
0.6744 |
Remote Similarity |
NPD8295 |
Clinical (unspecified phase) |
0.6724 |
Remote Similarity |
NPD7983 |
Approved |
0.6718 |
Remote Similarity |
NPD8377 |
Approved |
0.6718 |
Remote Similarity |
NPD8294 |
Approved |
0.6695 |
Remote Similarity |
NPD6356 |
Clinical (unspecified phase) |
0.6695 |
Remote Similarity |
NPD1698 |
Clinical (unspecified phase) |
0.6694 |
Remote Similarity |
NPD6412 |
Phase 2 |
0.6692 |
Remote Similarity |
NPD6314 |
Approved |
0.6692 |
Remote Similarity |
NPD6313 |
Approved |
0.6667 |
Remote Similarity |
NPD5248 |
Approved |
0.6667 |
Remote Similarity |
NPD5251 |
Approved |
0.6667 |
Remote Similarity |
NPD5247 |
Approved |
0.6667 |
Remote Similarity |
NPD5250 |
Approved |
0.6667 |
Remote Similarity |
NPD5249 |
Phase 3 |
0.6667 |
Remote Similarity |
NPD6909 |
Approved |
0.6667 |
Remote Similarity |
NPD6908 |
Approved |
0.6667 |
Remote Similarity |
NPD6291 |
Clinical (unspecified phase) |
0.6641 |
Remote Similarity |
NPD8133 |
Approved |
0.664 |
Remote Similarity |
NPD5128 |
Approved |
0.6639 |
Remote Similarity |
NPD7632 |
Discontinued |
0.6639 |
Remote Similarity |
NPD5222 |
Approved |
0.6639 |
Remote Similarity |
NPD5220 |
Clinical (unspecified phase) |
0.6639 |
Remote Similarity |
NPD5221 |
Approved |
0.6639 |
Remote Similarity |
NPD4697 |
Phase 3 |
0.6638 |
Remote Similarity |
NPD7838 |
Discovery |
0.6618 |
Remote Similarity |
NPD6033 |
Approved |
0.6614 |
Remote Similarity |
NPD8413 |
Clinical (unspecified phase) |
0.661 |
Remote Similarity |
NPD7901 |
Clinical (unspecified phase) |
0.661 |
Remote Similarity |
NPD7900 |
Approved |
0.6594 |
Remote Similarity |
NPD7260 |
Phase 2 |
0.6585 |
Remote Similarity |
NPD4754 |
Approved |
0.6583 |
Remote Similarity |
NPD5173 |
Approved |
0.6581 |
Remote Similarity |
NPD7515 |
Phase 2 |
0.6581 |
Remote Similarity |
NPD6079 |
Approved |
0.6557 |
Remote Similarity |
NPD1700 |
Approved |
0.6555 |
Remote Similarity |
NPD5210 |
Approved |
0.6555 |
Remote Similarity |
NPD4629 |
Approved |
0.6552 |
Remote Similarity |
NPD4753 |
Phase 2 |
0.6552 |
Remote Similarity |
NPD5328 |
Approved |
0.6552 |
Remote Similarity |
NPD1695 |
Approved |
0.6541 |
Remote Similarity |
NPD8517 |
Approved |
0.6541 |
Remote Similarity |
NPD8513 |
Phase 3 |
0.6541 |
Remote Similarity |
NPD8515 |
Approved |
0.6541 |
Remote Similarity |
NPD7503 |
Approved |
0.6541 |
Remote Similarity |
NPD8516 |
Approved |
0.6538 |
Remote Similarity |
NPD6868 |
Approved |
0.6529 |
Remote Similarity |
NPD8029 |
Clinical (unspecified phase) |
0.6525 |
Remote Similarity |
NPD5778 |
Approved |
0.6525 |
Remote Similarity |
NPD5779 |
Approved |
0.6525 |
Remote Similarity |
NPD4202 |
Approved |
0.6496 |
Remote Similarity |
NPD5785 |
Approved |
0.6484 |
Remote Similarity |
NPD5215 |
Approved |
0.6484 |
Remote Similarity |
NPD5216 |
Approved |
0.6484 |
Remote Similarity |
NPD5217 |
Approved |
0.6466 |
Remote Similarity |
NPD6672 |
Approved |
0.6466 |
Remote Similarity |
NPD5737 |
Approved |
0.6441 |
Remote Similarity |
NPD7637 |
Suspended |
0.6441 |
Remote Similarity |
NPD8035 |
Phase 2 |
0.6441 |
Remote Similarity |
NPD8034 |
Phase 2 |
0.6435 |
Remote Similarity |
NPD3618 |
Phase 1 |
0.641 |
Remote Similarity |
NPD6080 |
Approved |
0.641 |
Remote Similarity |
NPD6673 |
Approved |
0.641 |
Remote Similarity |
NPD6904 |
Approved |
0.6406 |
Remote Similarity |
NPD5169 |
Approved |
0.6406 |
Remote Similarity |
NPD5135 |
Approved |
0.6406 |
Remote Similarity |
NPD5134 |
Clinical (unspecified phase) |
0.6379 |
Remote Similarity |
NPD7524 |
Approved |
0.6357 |
Remote Similarity |
NPD5127 |
Approved |
0.6348 |
Remote Similarity |
NPD1694 |
Approved |
0.6348 |
Remote Similarity |
NPD5363 |
Approved |
0.6333 |
Remote Similarity |
NPD6001 |
Approved |
0.6316 |
Remote Similarity |
NPD7154 |
Phase 3 |
0.6316 |
Remote Similarity |
NPD6110 |
Phase 1 |
0.6316 |
Remote Similarity |
NPD5362 |
Discontinued |
0.6312 |
Remote Similarity |
NPD6845 |
Suspended |
0.6304 |
Remote Similarity |
NPD8074 |
Phase 3 |
0.6303 |
Remote Similarity |
NPD5284 |
Approved |
0.6303 |
Remote Similarity |
NPD5281 |
Approved |
0.6303 |
Remote Similarity |
NPD5693 |
Phase 1 |
0.6303 |
Remote Similarity |
NPD6050 |
Approved |
0.6293 |
Remote Similarity |
NPD6409 |
Approved |
0.6293 |
Remote Similarity |
NPD7334 |
Approved |
0.6293 |
Remote Similarity |
NPD5330 |
Approved |
0.6293 |
Remote Similarity |
NPD7521 |
Approved |
0.6293 |
Remote Similarity |
NPD6684 |
Approved |
0.6293 |
Remote Similarity |
NPD7146 |
Approved |
0.6261 |
Remote Similarity |
NPD7338 |
Clinical (unspecified phase) |
0.6261 |
Remote Similarity |
NPD4786 |
Approved |
0.6239 |
Remote Similarity |
NPD3573 |
Approved |
0.6228 |
Remote Similarity |
NPD4752 |
Clinical (unspecified phase) |
0.6218
|
Remote Similarity |
NPD5692 |
Phase 3 |